What is Alpha Stats?
Alpha Stats, Inc. operates as a specialized Contract Research Organization (CRO) providing high-level biostatistics, statistical programming, and medical writing services. With a leadership team boasting over 25 years of industry experience, the firm ensures rigorous adherence to GCP, ICH, and FDA guidelines. The company distinguishes itself through a flexible service model that integrates seamlessly with client teams, offering both on-site and remote support. By expanding its core competencies to include clinical data management and pre-clinical research, Alpha Stats is effectively broadening its value proposition to address the end-to-end needs of modern drug development pipelines.
How much funding has Alpha Stats raised?
Alpha Stats has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
Key Investors in Alpha Stats
PPP
Public-Private Partnership
What's next for Alpha Stats?
With the infusion of this recent capital, Alpha Stats is poised to accelerate its strategic roadmap, focusing on the integration of advanced clinical data management systems and the expansion of its pre-clinical research capabilities. The firm intends to utilize these resources to deepen its technical bench, ensuring that its statistical methodologies remain at the forefront of industry standards. As the pharmaceutical sector continues to demand higher precision in clinical trial outcomes, Alpha Stats is strategically positioned to capture increased market share by providing the analytical rigor necessary for successful regulatory submissions and accelerated product development cycles.
See full Alpha Stats company page
